Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CLRB - Cellectar Biosciences: Still Working On That Hit (Maintain Buy)

CLRB - Cellectar Biosciences: Still Working On That Hit (Maintain Buy)

Cellectar Biosciences Inc.

2024-05-20 13:02:41 ET

Summary

  • Cellectar Biosciences, Inc. is focused on developing a radiopharmaceutical for Waldenstrom's macroglobulinemia, a type of non-Hodgkin lymphoma.
  • The company has positive topline data from a pivotal study, with a high response rate in patients with Waldenstrom's macroglobulinemia.
  • Cellectar Biosciences has a strong pipeline and potential for commercialization, but cash concerns and the timeline for approval are risks.

Topline Summary and Update

For further details see:

Cellectar Biosciences: Still Working On That Hit (Maintain Buy)
Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...